Smmnary. Pancreatic islets removed from adult rats injected with streptozotocin during the neonatal period display an impaired secretory response to D-glucose and, to a lesser extent, to L-leucine. Despite normal to elevated hexokinase and glucokinase activities in the islets of these glucose-intolerant animals and despite normal mitochondrial binding of the hexokinase isoenzymes, the metabolic response to a high concentration of D-glucose is severely affected, especially in terms of D-[6-14C]glucose oxidation. Thus, the ratio in D-[6-14C]glucose oxidation/D-[5-3H]glucose utilization is much less markedly increased in response to a rise in hexose concentration and, at a high concentration of D-glucose (16.7 mmol/1), less markedly decreased by the absence of Ca 2t and presence of cycloheximide in diabetic than control rats. This metabolic defect contrasts with (1) a close-to-normal or even increased capacity of the islets of diabetic rats to oxidize D- [6-14C] (4) a modest perturbation of glycotysis. The most obvious alteration in glycolysis consists in a lesser increase of the glycolytic flux in response to a rise of D-glucose concentration in diabetic than control rats, this coinciding with an apparent decrease in affinity of glucokinase for the hexose. It is speculated that the preferential impairment of the metabolic and secretory response to D-glucose may be mainly attributable to an altered coupling between calcium accumulation and the stimulation of oxidative events in Beta-cell mitochondria of diabetic rats.
The release of insulin evoked by D-glucose in the pancreatic Beta cell is impaired in adult rats injected with streptozotocin during the neonatal period [1] [2] [3] . In this model of non-insulin-dependent diabetes, the impairment of insulin secretion coincides with, and might be attributable to, a decrease in the oxidative response of islet cells to a high concentration of the hexose [3] . This decrease in D-[U-14C]glucose oxidation and 02 consumption contrasts with a close-to-normal rate of glycolysis [3] . The major aims of the present study are to compare the oxidation of D-glucose and other nutrients in the islets of diabetic and control rats, to further explore the reciprocal coupling between functional and mitochondrial oxidative events in the islets isolated from either control or diabetic animals, and to assess the possible relevance of mitochondrial hexokinase isoenzymes binding to the alteration of the metabolic islet response in diabetic rats.
Materials and methods
Control rats and animals hajected with streptozotocin [4] during the neonatal periods were given free access to food [5] up to the time of killing. The rats were weighed and then decapitated, blood being collected in heparinized tubes. After centrifugation for 10 min at 1000 g and 4 ~ the plasma was removed and stored at -20 ~ The plasma glucose was measured by the glucose oxidase method [6] in 10 gl of plasma, and the plasma insulin in 100 gl of plasma using a radioimmunoassay described elsewhere [7] . In each experiment, islets were isolated by the collagenase method [8] from the pancreases of three to four rats. Two groups of 15 islets each were sonicated (3 x 10 s) in 0.25 ml H20 for measurement of islet protein by the method of Lowry et al. [9] using bovine albumin as standard. An aliquot (25 gl) of the islet homogenate was mixed with 1.0 ml of a phosphate buffer (100 mmol/l, pH 7.0) containing bovine albumin (1.0%, weight/volume) and stored at -20 ~ for measurement of the islet insulin content [8] .
For measurement of insulin release, groups of eight islets each were incubated for 120 min at 37 ~ in 1.0 ml of a bicarbonate-buf- (16) 48.6 + 4.8 (31)" -L-leucine(20.0mmol/1) 55.5+_ 5.9 (16) 34.0_+2.7 (31) a p < 0.001 vs control rats fered medium [8] containing bovine albumin (5 mg/ml) and equilibrated against a mixture of 02 (95%) and CO2 (5%). The amount of insulin released in the media was measured as described elsewhere [8] .
In all metabolic studies, groups of 15 to 20 islets each were incubated for 120 min at 37 ~ in 40 gl of the same bicarbonate-buffered medium containing, as required, both D- [5-3H] glucose and D- [6-14C] glucose or only a 14C-labelled nutrient. The incubation was halted by addition of 20 gl of a citrate-NaOH buffer (400 mmol/1, pH 4.9) containing antimycin A (0.01 mmol/1), rotenone (0.01 mmol/1) and KCN (5.0mmol/1). The oxidation of 14C-labelled nutrients was measured as described elsewhere [10] , the 14CO2 being trapped in hyamine hydroxide over 60 rain incubation at room temperature. When the medium also contained D- glucose, the recovery of ~H20 in 0.5 ml of H20 was then completed over a further incubation of 22 h at room temperature [11] . The acidified incubation media containing the islets were then stored at -20 ~ and later used for measurement of their content in either 14C-labelled amino acids, acidic metabolites or lactate. For these measurements, the islets were disrupted by freezing and thawing. The 14C-labelled amino acids (e. g. alanine generated from [2-14C]pyruvate) and acidic metabolites (e. g. 2-ketoisocaproate generated from L-[UsaC]leucine) were separated from their precursors by chromatography on a Dowex 50 H + column, as previously described [12] . For the assay of 14C-labelled lactate (generated from D-[6-~4C]glucose) two aliquots (40 ~tl each) taken from distinct vials were pooled together, heated for 10 min at 70 ~ and neutralized by the addition of 15 btl NaOH (1.0 mol/1). Samples (40 tal each) of the neutralized extract were then mixedwith a reaction mixture and incubated with or without lactate dehydrogenase for determination of ~4C-labelled lactate, as described elsewhere [13] .
For measuring the activity of hexokinase and glucokinase, groups of 400 to 600 islets were homogenized in Potter-Elvehjem Table 2 . Oxidation or utilization rate of nutrients by pancreatic islets 655 tubes (20 strokes) in 0.3 ml of a Hepes-NaOH buffer (10 mmol/1, pH7.0) containing 250mmol/1 sucrose, 2mmol/1 EDTA and 2 mmol/1 L-cysteine. After 3 min centrifugation at 1000 g in order to remove nuclei, cell debris and intact cells, 0.25 ml of the supernatant was again centrifuged for 60 min at 100,000 g and 4 ~ [14] . The supernatant of this second centrifugation and the corresponding pellet (resuspended in the same volume of the same buffer) were both sonicated (3 x 10 s) and examined for their glucose-phosphorylating activity, which was measured in aliquots of 10 to 30 gl, over 60 min incubation at 37 ~ in the presence of 2.0 mmol/1 ATFP and in a final volume of 60 gl, using a radioisotopic procedure previously described [15] .
Statistical analysis
All results are expressed as the mean (_+ SEM) together with the number of individual determinations (n), each collected in a distinct rat or group of islets, or degree of freedom (d. f.) and statistical significance of differences as assessed by use of Student's t-test. The SEM on the sum, difference or ratio between mean values was calculated as indicated elsewhere [16, i7] .
Results

Metabolic status and islet function
The body weight was lower in diabetic than control rats, but the former animals were also younger than the latter ones (Table 1) . When examined in the fed state, the plasma glucose concentration was higher in diabetic than control rats, but no significant difference was found in the plasma insulin concentration.
The mean islet protein content was somewhat lower, but not significantly so (p > 0.2), in diabetic than control rats, whilst the insulin content of the islets was severely decreased in the diabetic animals.
The basal insulin release, as measured over 120 rain incubation in the absence of exogenous nutrient, was not significantly different (p > 0.05) in islets removed from control and diabetic rats, respectively (Table 1 ). In the presence of either D-glucose (16.7 mmol/l) or L-leucine (20.0 mmol/1), however, the secretory rate was lower in diabetic than control rats. The hexose-induced increment : not significant) of differences between control and diabetic rats in insulin output was four times higher (p < 0.001) in control (111.7 _+ 14.4 gU/islet per 120 min) than diabetic rats (28.2 + 5.4 ~tU/islet per 120 rain). The increment in insulin output evoked by L-leucine was not significantly different (p>0.1), however, in control (25.9+9.1gU/islet per 120 rain) and diabetic rats (13.6 + 3.5 gU/islet per 120 rain). These data suggest that, in the diabetic rats, the secretory response to the amino acid was less severely impaired than that evoked by the hexose.
Islet metabolism
When the oxidation of D-
]leucine was measured in salt-balanced media and at low, non-insulinotropic, concentrations of these nutrients, no significant impairment of z4CO2 production was detected in the diabetic rats ( (Table 2 , Expt. 2), the rate of glycolysis, as judged through the production of BH20 from D-[5-3H]glucose, was not significantly ,different in diabetic and control rats at a low concentration of the hexose (2.8 mmol/1). However, at a higher concentration of D-glucose (16.7 mmol/1), the rate of glycolysis was slightly lower in diabetic than control animals. Moreover, the 2.8/16.7 mmol/1 ratio in 3H20 production was significantly higher (p>0.01) in diabetic (33.8+2.7%) than control rats (23.5+2.3%). In other words, the rise in glucose concentration caused a lesser increase of glycolytic rate in diabetic than control rats. Likewise, whereas the rate of D-[6-14C]glucose oxidation was not significantly different in control and diabetic rats at a low concentration of the hexose, it was much lower (p < 0.001) in the diabetic than control animals at a high concentration of D-glucose.
The (Fig. 1) . Thus, the rise in D-glucose concentration caused a preferential stimulation of the oxidation of acetyl residues in the Krebs cycle, relative to the rate of glycolysis, in both control and diabetic rats (p < 0.005). However, the relative magnitude of such a preferential stimulation was lower (p < 0.02) in diabetic ( + 37.1 + 12.3%) than control rats ( + 76.0 +_ 10.6%).
In order to gain further insight into the significance of these metabolic changes, the experiments conducted in the presence of 16.7 mmol/1 D-glucose were repeated in media deprived of CaCla and enriched with both EGTA (0.25 retool/l) and cycloheximide (0.05 mmol/1). Under the latter experimental conditions, which aimed at suppressing the functional response of islet cells to D-glucose [11] , the rate of D-[5-gH]glucose utilization was not significantly affected, whether in control or diabetic animals. The absence of Ca 2+ and presence of cycloheximide significantly decreased (p < 0.005), however, the rate of D-[6J4C]glucose oxidation, in both control and diabetic rats. The ratio between D-[6-t4C]glucose oxidation and D-[5-gH]glucose utilization was also markedly decreased, in both control and diabetic rats (Fig. 1) . Once again, the relative magnitude of the latter change was more pronounced (p < 0.025) in control ( -46.2 + 4.1%) than diabetic rats ( -30.4 + 5.4%).
The study of D-[6-14C]glucose catabolism by intact islets also included the measurement of 14C-labelled lactate production. Expressed as pmol of glucose residue/islet per 120 rain, it averaged, in control and diabetic rats respectively, 16 In both control and diabetic rats, the rate of aerobic glycolysis, taken as the difference between the production of 3H20 from D- [5-3H] glucose and the generation of [14C]labelled lactate, increased significantly (p > 0.001) in response to a rise in D-glucose concentration from 2.8 to 16.7 mmol/1. Moreover, when expressed relative to the corresponding total glycolytic flux, the fractional contribution of aerobic glycolysis also increased as the concentration of D-glucose was raised from 2.8 to 16.7 mmol/1. The magnitude of such a change was comparable in normal and diabetic rats and, pooling all available data collected in both types of rats, corresponded to an increase in the fractional contribution of aerobic to total glycolysis from 47.2+5.0% in the presence of 2.8 mmol/1 D-glucose to 61.3 + 3.0% in the presence of 16.7 mmol/1 D-glucose (p < 0.02).
The last experiments in this series aimed at comparing the oxidation of D-. . This indicates that, in terms of the interdependency between oxidative and functional responses, the situation in diabetic animals was again more severely perturbed in glucose-than leucinestimulated islets.
The operation of transamination reactions in intact islets was also investigated by measuring the generation of 14C-labelled amino acids in islets exposed to [2-~4C] pyruvate and that of 14C-labelled acidic metabolites in islets exposed to L-[U-14C]leucine (Table 3 ). The generation of 14C-labelled amino acids, presumably mainly [2-~4C]alanine, by islets exposed to [2-14C]pyruvate was not significantly different in normal and diabetic rats. The generation of lgC-labelled acidic metabolites, mainly [U-14C]2-ketoisocaproate [18] , by islets exposed to L-[U-~4C]leucine was higher (p < 0.001) in diabetic than control rats, when the amino acid was tested at a low concentration (1.0 mmol/1). Such a difference was no longer observed, however, when L-leucine was tested at a concentration of 20.0 mmol/1. In the latter case, the absence of Ca 2 + and presence of cycloheximide decreased (p < 0.005) the generation of ~4C-labelled acidic metabolites in both control and diabetic rats. The relative extent of such an inhibition was somewhat less marked, albeit not significantly so, in diabetic rats ( -30.6 + 9.0%; d. f. = 48) than con- 
D-glucose phosphorylation by islet homogenates
Because of the preferential perturbation of D-glucose catabolism in the islets of diabetic rats and in view of the essential role currently ascribed to D-glucose phosphorylation in the regulation of hexose metabolism in islet cells, the activity of hexokinase and glucokinase in islet homogenates was examined in the last part of the present M.-H. Giroix et al.: Islet oxidative response to D-glucose study. Moreover, because of the potential regulatory role of hexokinase isoenzymes binding to mitochondria, the enzymatic data were collected in both a particulate and soluble subcellular fractions prepared from the islet crude homogenates.
The total activity of hexokinase, as measured in the presence of 0.6 mmol/1 D-glucose, was higher in diabetic than control rats, averaging respectively 6.08 + 0.44 and 4.47 + 0.05 pmol/islet per rain (p < 0.005). The relative contribution of cytosolic and mitochondrial material to the total rate of hexose phosphorylation was not significantly different in control and diabetic rats (Table 4) . Dglucose 6-phosphate (initial concentration: 3.0 mmol/l) severely inhibited hexokinase activity. In both control and diabetic rats, the relative extent of such an inhibition was higher (p < 0.001) in the cytosolic than mitochondrial material, as expected from prior observations [14, 19] .
The total activity of glucokinase, as judged from the paired difference in the phosphorylation rate of D-glucose tested at concentrations of 0.6mmol/1 and 10.0 mmol/1 respectively, was not significantly different (p > 0.2) in control (1.39 + 0.16 pmol/islet per min) and diabetic rats (1.65 + 0.13 pmol/islet per rain). It accounted, in control and diabetic animals respectively, for 23.9 + 2.7% and 21.8 • 1.6% of the total rate of hexose phosphorylation recorded in the presence of 10.0 mmol/1 D-glucose (Table 5 ). The fractional contributions of the soluble and particulate-bound glucokinase were similar in control and diabetic rats, accounting each for about half of the total enzymatic activity.
In the study of glucokinase activity, the sole difference between control and diabetic rats was observed when the concentration of unlabelled D-glucose was raised from 10 to 50 mmol/1, whilst keeping the concentration of D-[6-~4C]glucose unchanged. The decrease in the generation rate of D-[6-14C]glucose 6-phosphate resulting from such an increase in the concentration of unlabelled D-glucose was indeed less marked in diabetic than control rats (Fig. 2) . This difference was observed in both the cytosolic and mitochondrial fraction.
Discussion
The present study extends prior investigations on the metabolic and functional anomalies in islets prepared from adult rats which were injected with streptozotocin during the neonatal period [2, 3] . These anomalies may result from a long-lasting effect of streptozotocin [19] and/or mild hyperglycaemia. Our results suggest that the capacity of mitochondria to oxidize D-glucose, pyruvate, L-glutamine and L-leucine is not impaired in the diabetic rats, at least when these nutrients are tested at non-insulinotropic concentrations and even more so that the size of the islets might be somewhat lower in diabetic than control rats.
Likewise, the transamination data collected in intact islets indicate that there is no alteration of the latter process in diabetic rats. Since the generation of 2-ketoisocaproate from L-leucine, in the islets, is critically dependent on the activation of glutamate dehydrogenase by the amino acid [20] , these data also suggest that there is no obvious perturbation in the activity of the latter mitochondrial enzyme. Nevertheless, the fact that, in the presence of 20.0 mmol/1 L-leucine, the oxidation of the amino acid was lower in diabetic than control rats points to an alteration in the oxidative catabolism of 2-ketoisocaproate, generated from exogenous L-leucine, as a possible cause of the impaired secretory response to L-leucine recorded in the islets from diabetic rats. The latter secretory defect sharply contrasts with the increased responsiveness to L-leucine recorded in the perfused pancreas of diabetic rats [1] . The factors responsible for such contrasting behaviour of the Beta cell in the perfused pancreas and isolated islets, respectively, remain to be identified.
Three converging series of observations indicated that the metabolic and secretory response of islet cells was more severely perturbed in the case of D-glucose than L-leucine. First, as judged from the increment in insulin release evoked by these nutrients, the response to D-glucose was more markedly affected than that to L-teucine. Second, a preferential alteration of D-glucose catabolism was documented by the direct comparison of D- [6-~4C] glucose and L-[U-14C]leucine oxidation in both control and diabetic rats. In this respect, comparable results were obtained at low and high concentrations of these nutrient secretagogues. Third, the reciprocal coupling between oxidative and functional events, as judged from the changes evoked by the absence of Ca 2+ and presence of cycloheximide [11] , also indicated a severe alteration in the case of glucose-stimulated islets prepared from diabetic rats, whereas no significant difference between normal and diabetic rats was recorded when the same environmental factors were tested in leucine-stimulated islets.
The present results suggest that the preferential alteration of the Beta cell response to D-glucose in this model of non-insulin-dependent diabetes is not attributable to either a decrease in hexokinase and glucokinase activities or an altered binding of these isoenzymes to mitochondria. In the case of the high Km glucokinase, the sole perturbation in the diabetic animals resided in an apparently decreased affinity for D-glucose. The same change in the kinetic behaviour of glucokinase was recently observed in the liver of streptozotocin-induced diabetic adult rats [21] . This anomaly might possibly account, in part at least, for the lesser increase in glycolytic flux observed in the islets of diabetic rather than control rats in response to a rise in 659 extracellular D-glucose concentration from 2.8 to 16.7 mmol/1.
The absolute rate of glycolysis at the high concentration of D-glucose was little affected, however, in the islets of diabetic rats. The major metabolic anomaly in glucosestimulated islets from diabetic rats consisted in an impaired preferential stimulation of D-[6-14C]glucose oxidation. This mitochondrial defect coincided with a lesser sensitivity towards the absence of Ca 2 § and presence of cycloheximide of the same biochemical process, i.e. the oxidation of acetyl residues in the Krebs cycle in islets exposed to a high concentration of extracellular D-glucose. Recent observations ascribe a key role to the mitochondrial accumulation of calcium and subsequent activation of calcium-dependent mitochondrial dehydrogenases (e. g. glycerol phosphate dehydrogenase and 2-ketoglutarate dehydrogenase) in the preferential stimulation by D-glucose of mitochondrial oxidative events (such as circulation in the glycerol phosphate shuttle and acetyl residues oxidation in the Krebs cycle) in the islet cells [22, 23] . It is conceivable, therefore, that the altered response of pancreatic islets to either a rise in D-glucose concentration or the removal of Ca 2+, as judged from the ratio between D-[6-14C]glucose oxidation and D-[5-3H]glucose utilization, is mainly attributable to an alteration, at the mitochondrial level, of this reciprocal coupling between cationic and oxidative events.
In conclusion, although the perturbation of the Betacell secretory behaviour in the present model of non-insulin-dependent diabetes might be attributable to several distinct metabolic defects, our results point, nevertheless, towards an alteration in the interdependency of Ca 2 § handling and mitochondrial oxidative events as a major determinant of the preferential impairment of the Betacell responsiveness to D-glucose. In this respect, the present findings emphasize the view [24] that the transport of D-glucose across the plasma membrane and its subsequent phosphorylation by glucokinase should not be considered as the sole, possibly even not the major, regulatory factors of the functional response to D-glucose, whether in normal or diseased Beta cells.
